Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Global Psoriasis Atlas

THE FIRST-EVER GLOBAL DATABASE ON PSORIASIS

Project Description

The Global Psoriasis Atlas (GPA) is a joint project of the ILDS (International League of Dermatological Societies), IFPA (International Federation of Psoriasis Associations ), and IPC (International Psoriasis Council).

The mission of the GPA is to provide the common benchmark on the complete burden of psoriasis in all countries and regions throughout the world. The GPA will leverage existing data from publications and registries; where gaps are identified, additional studies will be commissioned.

The GPA is a long-term project that seeks to drive continuous improvement in the understanding of psoriasis and to uncover how it affects both the individual and society at large. While the first edition of the GPA focuses on the incidence and prevalence of psoriasis, future editions will be expanded to include access to treatment, comorbidities, and cost to society.  For more information, visit the GPA website.

Project Leaders

Christopher

Griffiths

,

OBE, MD, FMedSci

University of Manchester and King’s College London

London

,

United Kingdom

Program Director

IPC Honorary Founder

Darren

Ashcroft

,

BPharm, MSc, PhD, MRPharmS

University of Manchester

Manchester

,

United Kingdom

Research Director

IPC Councilor

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.

Name(Required)

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026